{"id":"W4406869295","doi":"10.1200/jco.2025.43.4_suppl.6","title":"GOBLET platform study: Preliminary safety and tumor response results for the relapsed anal carcinoma cohort in patients treated with pelareorep and atezolizumab.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Medicine; Atezolizumab; Cohort; Oncology; Internal medicine; Carcinoma; Surgery; Cancer; Pembrolizumab; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004532117,0.0001577262,0.001150547,0.0001914363,0.0001006188,0.00001142117,0.0001052706,0.0001663789,0.000004057879],"category_scores_gemma":[0.004229215,0.00008368894,0.0001434487,0.0002401445,0.0002751249,0.00007754476,0.00008644415,0.0007122555,3.156339e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001579172,"about_ca_system_score_gemma":0.0008225571,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007590943,"about_ca_topic_score_gemma":0.0002258563,"domain_scores_codex":[0.9971166,0.0003872741,0.00177888,0.0002690556,0.0002371405,0.0002110234],"domain_scores_gemma":[0.9924048,0.006128916,0.0007271363,0.0001744382,0.0003757054,0.0001890509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3798712,0.0008645884,0.6077384,0.00001697914,0.0001878297,0.0004888882,0.0001784669,0.00000259698,0.000003123105,0.00001232917,0.0003744121,0.01026112],"study_design_scores_gemma":[0.03870827,0.1033772,0.8537337,0.0001176246,0.000655805,0.0001804969,0.0006470756,0.0003281239,0.000005714063,0.00003967107,0.002134017,0.0000722506],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936745,0.0002599876,0.000006414951,0.004194954,0.0001588589,0.001067887,0.00001700852,0.000005407433,0.000615034],"genre_scores_gemma":[0.9986974,0.0000786966,0.0001148232,0.0005856373,0.0001025139,0.00001109829,0.000005360472,0.000009681137,0.0003947782],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.341163,"threshold_uncertainty_score":0.5063071,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04289859851674939,"score_gpt":0.3750636194387777,"score_spread":0.3321650209220283,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}